A
Aethlon Medical, Inc. (AEMD)
NCM – Real Time Price. Currency in USD
3.01
-0.17 (-5.30%)
At close: Aug 12, 2026, 3:58 PM EDT
3.04
+0.07 (2.36%)
After-hours: Aug 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.01
-0.17 (-5.30%)
At close: Aug 12, 2026, 3:58 PM EDT
3.04
+0.07 (2.36%)
After-hours: Aug 12, 2026, 4:10 PM EDT
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
| Name | Position |
|---|---|
| Dr. Steven P. LaRosa M.D. | Chief Medical Officer |
| Mr. James B. Frakes M.B.A. | CEO, CFO, Chief Accounting Officer, Secretary & Director |
| Ms. Michele Bombardiere | VP & Controller |
| Date | Type | Document |
|---|---|---|
| 2026-07-31 | 8-K | aethlon_8k.htm |
| 2026-07-08 | 8-K | aethlon_8k.htm |
| 2026-07-01 | S-1/A | aethlon_s1a1.htm |
| 2026-06-22 | S-1 | aethlon_s1.htm |
| 2026-06-10 | S-8 | aethlon_s8.htm |
| 2026-06-10 | 10-K | aethlon_i10k-033126.htm |
| 2026-06-04 | 8-K | aethlon_8k.htm |
| 2026-05-05 | DRS | filename1.htm |
| 2026-03-17 | 8-K | aethlon_8k.htm |
| 2026-02-23 | 8-K | aethlon_8k.htm |